Robocath, a company that designs cardiovascular robotic systems for the treatment of vascular diseases, has announced it has successfully completed its first robotic coronary angioplasties.
The Percutaneous Coronary Interventions (PCI) were performed using the 'R-One' robot system, by Professor Michael Haude, a recognised and highly experienced interventional cardiologist, and his team at Rheinland Klinikum Neuss Lukaskrankenhaus, Germany.
Prof. Haude said: “I’m proud to be the first user of this brand new European robotic solution for PCI in Germany. These robotic interventions pave the way for a new era in interventional cardiology. The benefits brought by R-One are huge for practitioners and will drastically improve our working conditions, which will consequently benefit patient care. My team and I look forward to integrating this robotic-assisted platform for PCI into our day-to-day clinical practice.”
Lucien Goffart, CEO of Robocath, said, “These first procedures in Germany are in line with our expansion strategy. We are very proud to achieve this important strategic step and to see our first robot used in this key market. There is a momentum for vascular roboticsas it completely addresses the medico-economic challenges of modern healthcare systems. The interest of major industry players is a clear indicator of this; it demonstrates that the penetration of robotics in the medical sector is now irreversible.”
